Novarties India has completed the transaction of selling its animal health business to Elanco India, an affiliate of Eli Lilly.
Novartis India has said in s BSE filing that “Following the approval from the Foreign Investment Promotion Board (FIPB), Indian government and Competition Commission of India, we wish to inform you that the transaction for the transfer of the company’s animal health division to Elanco India has been completed”.
